Summary.-Procarbazine has been shown to be a hypoxic cell sensitizer of moderate ability in E. coli B/r, with an achievable enhancement ratio of 1-4 at subtoxic concentrations. The drug appears to act in a manner similar to that expected with the electronaffinic radiosensitizers. However, procarbazine and the electron-affinic sensitizers differ in two important respects. Unlike the electron-affinic sensitizers, procarbazine is not easily reduced, but is easily oxidized. It is more toxic to aerobic than to hypoxic cells. At the drug dosages in present clinical use, procarbazine is likely to be only a weak radiosensitizer. The possible implications of the data for the further development of a new class of sensitizers and combination therapy are discussed.
for clinical use, and trials are now in progress (Urtasun et al., 1976; Thomlinson et CH3 al., 1976) . The :nitro-heterocyclic sensi-(Ix) AzoDerivative tizers have been shown to be preferentially toxic to hypoxic cells (Hall & RoizinTowle, 1975; Mohindra & Rauth, 1976 ; procarbazine can be regarded as a deriva- Stratford & Adams, 1977) . This finding tive of methyl hydrazine, itself a radiation coincides with a growing awareness of the sensitizer (Moroson & Spielman, 1966) . potential of combined-modality treat-Clinical use of procarbazine during radioments. therapy has already been made. Claims Procarbazine (I) is a cytotoxic agent for a therapeutic advantage over radiation used singly or in combination, principally alone have been advanced (Sandison et al., in the treatment of Hodgkin's disease 1967; Falkson et al., 1970) and denied (Spivak, 1974) . It contains an aromatic (Landgren et al., 1973) . It was felt that a ketone grouping (see I), which formed the fundamental study of the toxicity and basis on which several of the original sensitizing properties of procarbazine electron-affinic sensitizers were chosen might clarify the potential of this com- (Adams & Cooke, 1969) . Alternatively, pound as a radiation sensitizer.
Overnight cultures of E. coli B/r grown at 37°C in tryptone-glucose-yeast (TGY) medium were re-inoculated into fresh medium and allowed to grow to late log phase. The cells were filtered and washed in buffer (66mMi phosphate salts at pH 7-0+0-1) and resuspended in a little buffer. Unless otherwise stated a final suspension in buffer (107 eells/ ml) was made about 40 min after the cells were harvested. Survival after exposure to irradiation or procarbazine was determined by dilution into buffer, followed by plating out on TGY-agar and overnight incubation at 37°C. Most experiments were carried out at room temperature (about 22°C) but a few toxicity experiments were performed at 37°C. In both the irradiation and toxicity experiments, either moist air or N2 (<12 parts/106 02 as determined in the effluent gas by Hersch-cell measurement) wNas passed continuously through the suspension. Irradiations were carried out in a Gammacell 220 60Co source at a dose rate of about 11 krad/min.
Procarbazine Radiation sensitization by procarbazine The duration of exposure to the drug was no more than 20 min in the following experiments and, at the highest concentrations reported, drug toxicity reduced survival by less than 20%. The Do values for aerobic and hypoxic cells in the absence of drug were 6 9 (p0 9) krad and 19*3 (11I0) krad respectively (Fig. 2) . Procarbazine had no effect on the survival of E. coli B/r when present during the irradiation of aerobic cells, but sensitized hypoxic cells (Fig. 2) . Sensitization was purely dosemodifying, and did not occur unless procarbazine was present at the time of irradiation. Enhancement ratios of 1.15, 1-25 and 1-4 were found for procarbazine concentrations of 0'25 mm, 0 50 mm and 1 mM respectively. These enhancements should be compared with an oxygen enhancement ratio (OER) of 2-8 in the same system and enhancements for some nitroheterocyclic sensitizers of 1.9 for 0-25mm nifuroxime, 1.3 for 1mM metronidazole and Oliverio, 1970) , the high tissue concentrations that this study would indicate to be necessary for a relatively small enhancement, and the potential carcinogenicity of procarbazine (Anderson, 1976 Landgren et al. (1973) found no beneficial effect of a combined treatment. This was in contrast to an earlier South African study in which a significant (P 0.15) increase in one year survival was claimed (Sandison et al., 1967) . In the latter study the irradiation schedule was different in the test and control groups. The South African workers also reported that procarbazine brought about an objective improvement in the radiation treatment of malignant melanomas and mesotheliomas (Falkson et al., 1970) . In the trials, doses of procarbazine were in the range 50-450 mg/day. The results presented above indicate that, unless procarbazine is a more effective sensitizer of mammalian cells than of bacteria, or is concentrated in tumour tissue, far higher dosages than the 100 mg/M2 used in normal clinical practice would be required to achieve a useful enhancement of radiation effects.
Redox properties of procarbazine
The nitro-aromatic hypoxic cell sensitizers of current interest for their application to therapy evolved from an initial theory that such sensitizers acted by virtue of their electron affinity (Adams & Dewey, 1963; Adams & Cooke, 1969) . It has been established that the efficiency of a sensitizer and its aerobic cytotoxicity are directly related to its one-electron reduction potential at pH 7 (E71). The more positive is E7 1, the greater is the efficiency and toxicity of the sensitizer (Adams et al., 1 976a, b). Procarbazine has a chemical structure reminiscent of the early electronaffinic sensitizers. Its redox properties have not been reported and have been inferred in this work polarographically. Polarography can only be a rough guide to redox properties, but the results were quite clear. A fresh solution of procarbazine was not reduced at a potential more positive than -1500 mV, the limiting negative potential in our system. Oxidation occurred at a half-wave potential of about 100 mV. This relatively easy polarographic oxidation is consistent with the known aerobic and in vivo oxidation of procarbazine to Compound II (Oliverio, 1970) .
In view of the ability of procarbazine to sensitize hypoxic cells selectively, it is perhaps surprising that procarbazine has such a low electron affinity (i.e., it cannot be easily reduced). It is pertinent to ask whether it is an oxidation product of procarbazine that is the true sensitizing agent. Two types of experiment were performed in an attempt to answer this question. Firstly, cells were exposed to a fresh procarbazine solution under aerobic conditions for 1 h. The cells and the solution were then separated. Irradiation of the procarbazine-exposed cells in buffer and under hypoxia showed that only a very slight enhancement (<1I1) could be observed. This may not be significant, and could be due to carry-over of intracellular procarbazine. It was shown that the separated solution had a similar sensitizing ability to a procarbazine solution which had not been pre-exposed to cells. Secondly, the sensitizing ability of a Imm procarbazine solution was followed as the solution was allowed to oxidize on standing in air. No significant change in sensitizing ability was noted over the first few days, and on about Day 4 the solution became excessively toxic. During this latter experiment the oxidative degradation of the procarbazine solution was followed by analytical thin-layer chromatography and polarographically. The procarbazine was initially chromatographically pure. Within 1 h of making up a solution, a species capable of reduction at a half-wave potential of about 600 mV could be detected. This species could be Compound II. The published data (e.g. Greenstock et al., 1976; Adams et al., 1976a) suggest that compounds with a reduction potential as negative as 600 mV will be, at best, very inefficient sensitizers. In the time scale of the usual irradiation experiments, the amount of any oxidation products was less than 1% of the original procarbazine concentration, according to TLC analysis. A significant contribution to sensitization from the production of reducible species as the solution ages appears unlikely. Both polarography and TLC indicated that the subsequent further degradation of procarbazine was complex. No species with more positive half-wave reduction potentials than 600 mV were detected. The above data imply that it is procarbazine itself which causes the sensitization of irradiated hypoxic cells. However, it is conceded that only a crude assessment of any contribution from the intracellular degradation of procarbazine was possible. Intracellular processes may be both more rapid and different from those monitored in the experiments outlined above and a contribution from such processes cannot be entirely ruled out.
Conmparison with other work
The relationships between E7 1, sensitization and toxicity for electron-affinic sensitizers referred to above have been established recently using mammalian cells (Adams et al., 1976a, b) . To assess the present results more fully, it was necessary to establish that the same relationships apply in our bacterial system. The Table   TABLE. Roizin-Towle, 1975; Mohindra & Rauth, 1976; Stratford & Adams, 1977) . A similar effect in E. coli B/r was found during this work (Fig. 3) .
CONCLUSIONS
Procarbaziine is capable of the radiation sensitization of hypoxic cells. The enhancements achieved at concentrations which approach toxic levels in bacteria are modest, however, and the clinical relevance of this finding is uncertain at present. Of more interest are the implications of this study for the further development of hypoxic cell sensitizers and for combination chemotherapy/radiotherapy. Procarbazine shows clear differences when compared with the nitro-heterocyclic radiosensitizers on which attention has been focused. It is not easily reduced, but easily oxidized (i.e., it tends to donate rather than accept electrons). Like the nitro-heterocyclic compounds, procarbazine is a selective hypoxic cell radiosensitizer; however, it is more toxic to aerobic than to hypoxic cells. Careful delineation of the selective toxic and radiosensitizing properties of any drug proposed for use in conjunction with radiotherapy is indicated. One of the theories 759 A advanced to account for the selective toxicity of the nitro-heterocyclic compounds invokes interference with electrontransport processes (Adams et al., 1976b) . The fact that procarbazine, which is electron-donating rather than electronwithdrawing, exhibits selective toxicity which is the reverse of that found with the nitro-heterocyclics may lend support to the electron-transport theory.
If it is accepted that procarbazine itself and not an oxidation product acts as the sensitizing agent, a comment relevant to the mechanism of sensitization can be made. Electron-affinic, hypoxic cell sensitizers are thought to enhance radiation damage by promoting electron withdrawal from a damaged target site (Adams, 1972) . It is tempting to speculate that procarbazine acts by electron donation, i.e. in a complementary fashion to the electronaffinic compounds. However, it has been suggested (Lohman, 1974) that electron donation will result in radiation protection rather than sensitization. The protective influence of oxidizable compounds such as sulphydryl and related chemicals (Adams, 1972; Pihl & Sanner, 1970) would support such a suggestion. Procarbazine may be a unique sensitizing agent. However, if ease of oxidation can be associated with hypoxic cell sensitization under certain conditions, the examination of compounds with a range of oxidation potentials may suggest a fresh class of potentially useful radiosensitizers.
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